Koru Medical Systems vs Trisalus Life Sciences
Koru Medical Systems and Trisalus Life Sciences are similar in size: $41.1m and $45.2m of revenue in their latest fiscal years. Trisalus Life Sciences grew faster (53.4% against 22.2%). Koru Medical Systems kept more of each dollar of sales as profit: a net margin of -6.4% against -86.9%.
| Latest fiscal year | Koru Medical SystemsKRMD, 2025 | Trisalus Life SciencesTLSI, 2025 |
|---|---|---|
| Revenue | $41.1m | $45.2m |
| Revenue growth | 22.2% | 53.4% |
| Net income | −$2.6m | −$39.2m |
| Operating margin | -7.2% | -59.7% |
| Net margin | -6.4% | -86.9% |
| Return on equity | -15.6% | — |
| Free cash flow | −$470,112 | −$18.9m |
| Cash | $8.9m | $20.4m |
| Total debt | $0 | $33.0m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 73 | 102 |
| Market value | $143m | $213m |
| Price vs our value range | — | — |
| Moat score | 46 (Moderate) | — |
| Insider trades, 12 months | 9 buys, 0 sales | 12 buys, 18 sales |